Kubota Pharmaceutical Holdings Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was JPY 1,196.84 million compared to JPY 1,351 million a year ago. Basic loss per share from continuing operations was JPY 26.02 compared to JPY 29.86 a year ago.

Diluted loss per share from continuing operations was JPY 26.02 compared to JPY 29.86 a year ago.